PortfoliosLab logoPortfoliosLab logo
NVT vs. GMED
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NVT vs. GMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in nVent Electric plc (NVT) and Globus Medical, Inc. (GMED). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NVT achieves a 58.14% return, which is significantly higher than GMED's -10.54% return.


NVT

1D
1.69%
1M
-2.31%
6M
53.03%
YTD
58.14%
1Y
116.38%
3Y*
47.35%
5Y*
40.99%
10Y*

GMED

1D
1.92%
1M
-2.99%
6M
-17.32%
YTD
-10.54%
1Y
36.75%
3Y*
8.91%
5Y*
-0.63%
10Y*
12.07%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NVT vs. GMED - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
NVT
nVent Electric plc
58.14%51.27%16.63%55.98%3.32%67.15%-5.68%17.24%7.52%
GMED
Globus Medical, Inc.
-10.54%5.56%55.21%-28.25%2.87%10.70%10.77%36.04%-15.45%

Correlation

The correlation between NVT and GMED is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.22

Correlation (3Y)
Calculated over the trailing 3-year period

0.32

Correlation (5Y)
Calculated over the trailing 5-year period

0.38

Correlation (All Time)
Calculated using the full available price history since May 1, 2018

0.38

The correlation between NVT and GMED shifts across timeframes, from 0.22 (1 year) to 0.38 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

NVT:

$25.99B

GMED:

$10.53B

EPS

NVT:

$2.99

GMED:

$4.28

PE Ratio

NVT:

53.67

GMED:

18.23

PEG Ratio

NVT:

1.29

GMED:

0.19

PS Ratio

NVT:

6.10

GMED:

3.45

PB Ratio

NVT:

6.94

GMED:

2.28

Total Revenue (TTM)

NVT:

$4.33B

GMED:

$3.10B

Gross Profit (TTM)

NVT:

$1.60B

GMED:

$1.58B

EBITDA (TTM)

NVT:

$857.60M

GMED:

$803.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NVT vs. GMED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVT
NVT Risk / Return Rank: 9595
Overall Rank
NVT Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
NVT Sortino Ratio Rank: 9393
Sortino Ratio Rank
NVT Omega Ratio Rank: 9292
Omega Ratio Rank
NVT Calmar Ratio Rank: 9696
Calmar Ratio Rank
NVT Martin Ratio Rank: 9797
Martin Ratio Rank

GMED
GMED Risk / Return Rank: 7373
Overall Rank
GMED Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
GMED Sortino Ratio Rank: 7575
Sortino Ratio Rank
GMED Omega Ratio Rank: 7272
Omega Ratio Rank
GMED Calmar Ratio Rank: 7575
Calmar Ratio Rank
GMED Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVT vs. GMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for nVent Electric plc (NVT) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NVTGMEDDifference
Sharpe ratioReturn per unit of total volatility

+1.98

Sortino ratioReturn per unit of downside risk

+1.39

Omega ratioGain probability vs. loss probability

1.41

1.21

+0.21

Calmar ratioReturn relative to maximum drawdown

6.74

1.60

+5.14

Martin ratioReturn relative to average drawdown

20.34

3.87

+16.47

NVT vs. GMED - Sharpe Ratio Comparison

The current NVT Sharpe Ratio is 2.69, which is higher than the GMED Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of NVT and GMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NVT vs. GMED - Drawdown Comparison

The maximum NVT drawdown since its inception was -56.18%, which is greater than GMED's maximum drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for NVT and GMED.


Loading charts...

Drawdown Indicators


NVTGMEDDifference

Max Drawdown

Largest peak-to-trough decline

-56.18%

-47.91%

-8.27%

Max Drawdown (1Y)

Largest decline over 1 year

-17.46%

-22.10%

+4.64%

Max Drawdown (3Y)

Largest decline over 3 years

-46.67%

-44.40%

-2.27%

Max Drawdown (5Y)

Largest decline over 5 years

-46.67%

-47.91%

+1.24%

Max Drawdown (10Y)

Largest decline over 10 years

-47.91%

Current Drawdown

Current decline from peak

-12.81%

-19.32%

+6.51%

Average Drawdown

Average peak-to-trough decline

-11.80%

-15.33%

+3.53%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.77%

9.13%

-3.36%

Volatility

NVT vs. GMED - Volatility Comparison

nVent Electric plc (NVT) has a higher volatility of 17.61% compared to Globus Medical, Inc. (GMED) at 13.69%. This indicates that NVT's price experiences larger fluctuations and is considered to be riskier than GMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NVTGMEDDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.61%

13.69%

+3.92%

Volatility (6M)

Calculated over the trailing 6-month period

33.72%

25.33%

+8.39%

Volatility (1Y)

Calculated over the trailing 1-year period

43.68%

49.46%

-5.78%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

36.58%

38.27%

-1.69%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

38.71%

35.68%

+3.03%

Dividends

NVT vs. GMED - Dividend Comparison

NVT's dividend yield for the trailing twelve months is around 0.51%, while GMED has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018
GMED
Globus Medical, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVT
nVent Electric plc
0.51%0.78%1.12%1.18%1.82%1.84%3.01%2.74%1.56%

Financials

NVT vs. GMED - Financials Comparison

This section allows you to compare key financial metrics between nVent Electric plc and Globus Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M400.00M600.00M800.00M1.00B1.20BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
1.24B
759.85M
(NVT) Total Revenue
(GMED) Total Revenue
Values in USD except per share items

NVT vs. GMED - Profitability Comparison

The chart below illustrates the profitability comparison between nVent Electric plc and Globus Medical, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
35.9%
0
Portfolio components
NVT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, nVent Electric plc reported a gross profit of 445.60M and revenue of 1.24B. Therefore, the gross margin over that period was 35.9%.

GMED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.

NVT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, nVent Electric plc reported an operating income of 195.70M and revenue of 1.24B, resulting in an operating margin of 15.8%.

GMED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.

NVT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, nVent Electric plc reported a net income of 142.40M and revenue of 1.24B, resulting in a net margin of 11.5%.

GMED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.


Frequently Asked Questions


NVT and GMED have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NVT has higher volatility (17.61%) compared to GMED (13.69%). In terms of maximum drawdown, NVT dropped -56.18% vs GMED's -47.91%.

NVT currently has the higher Sharpe Ratio (2.69 vs 0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NVT and GMED

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer